Question 1

What is the catalog number for Egfr (Epidermal Growth Factor Receptor, Egfr) (MaxLight 650) discontinued?

Accepted Answer

The catalog number for Egfr (Epidermal Growth Factor Receptor, Egfr) (MaxLight 650) discontinued is 302409-ML650.

Question 2

What sizes are available for Egfr (Epidermal Growth Factor Receptor, Egfr) (MaxLight 650) discontinued?

Accepted Answer

Egfr (Epidermal Growth Factor Receptor, Egfr) (MaxLight 650) discontinued is available in the following size(s): 100 µL.

Question 3

Is Egfr (Epidermal Growth Factor Receptor, Egfr) (MaxLight 650) discontinued in stock?

Accepted Answer

Egfr (Epidermal Growth Factor Receptor, Egfr) (MaxLight 650) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can you help me confirm if this product is right for my specific experiment?

Accepted Answer

Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.

Question 5

What is the purity of this recombinant protein?

Accepted Answer

Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.

Question 6

What do I do if this product arrives with reduced ice or a damaged cold-chain package?

Accepted Answer

Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.

Egfr (Epidermal Growth Factor Receptor, Egfr) (MaxLight 650) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Olfr541 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

AMAC1 Lentiviral Activation Particles (h)

CCDC38 CRISPR Activation Plasmid (h2)

KIR3DL1 Mouse Monoclonal Antibody [Clone ID: OTI1A7]

Tmtc1 3'UTR Luciferase Stable Cell Line

Mouse Pogk (NM_175170) AAV Particle